About: http://data.cimple.eu/news-article/816cb482b4650aae6dc3b41ca214a011baabe018021939eab7d6735a

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://data.cimple.eu/news-article/816cb482b4650aae6dc3b41ca214a011baabe018021939eab7d6735a Goto Sponge NotDistinct Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

Attributes	Values
rdf:type	schema:NewsArticle
schema:articleBody	Wall Street continued its string of new records on Monday, as the Nasdaq and S&P 500 notched all-time highs amid promising news about a new coronavirus treatment. The benchmark Dow Jones Industrial Average also climbed, gaining nearly 1.4 percent by the closing bell to 28,308.46 following news the US Food and Drug Administration (FDA) had authorized use of an experimental COVID-19 treatment. The broad-based S&P 500 jumped 1.0 percent to end the session at 3,431.28, while the tech-rich Nasdaq Composite Index rose 0.6 percent to 11,379.72, its third consecutive high point, bringing the tally for the year closer to 40 records. Maris Ogg, portfolio manager at Tower Bridge Advisors, noted that while trading is quiet in late August, "We are slowly seeing the market broadening in terms of leadership, which is pretty healthy." Shares got a boost after the FDA on Sunday issued an "emergency use authorization" allowing doctors to administer plasma from people who have recovered from COVID-19 to treat new patients. "Based on scientific evidence available, the FDA concluded this product may be effective in treating COVID-19 and that the known and potential benefits of the product outweigh the known and potential risks of the product in hospitalized COVID-19 patients," the agency said in a statement. But Ogg noted that good news on a treatment was counteracted by worrying reports about coronavirus patients becoming reinfected. "COVID is still very much rattling people," she told AFP. "It will probably go on like this until we have a group of vaccines that people are confident in." Apple continued its upward march, but retreated from the high point of the day, closing with a gain of 1.2 percent at $503.43 ahead of a planned stock split. Meanwhile, American Airlines surged 10.5 percent after announcing it was using a special anti-viral spray in its airplane to combat COVID-19, and Delta Air Lines gained 9.2 percent after adding international flights. hs/cs
schema:headline	Nasdaq, S&P continue setting records amid COVID-19 treatment hope
schema:mentions	Closing Bell S&P 500 Index Tower Bridge Ogg Dow Jones Industrial Average Agence France-Presse Blood plasma American Airlines Delta Air Lines Apple Inc. Food and Drug Administration Coronavirus disease Severe acute respiratory syndrome coronavirus 2 Coronavirus disease 2019 Stock split West Seattle Investment management NASDAQ Composite
schema:author	http://data.cimple.eu/organization/1f0054d541e000623a2c1e561a247c073ef6328e8be9ffafda7b3fcd
schema:datePublished	2020-08-24 (xsd:date)
http://data.cimple...sPoliticalLeaning	other political leaning
http://data.cimple...logy#hasSentiment	negative sentiment
http://data.cimple...readability_score	61 (xsd:integer)
http://data.cimple...tology#hasEmotion	happiness

Faceted Search & Find service v1.16.115 as of Oct 09 2023

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 5 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software